Changjie Chen Selected Research

Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)

10/2018	The N-terminal polypeptide derived from vMIP-II exerts its anti-tumor activity in human breast cancer by regulating lncRNA SPRY4-IT1.
4/2017	N-terminal polypeptide derived from vMIP-II exerts its antitumor activity by inhibiting the CXCR4 pathway in human glioma.
8/2011	Suppression of breast cancer proliferation and induction of apoptosis via AKT and ERK1/2 signal transduction pathways by synthetic polypeptide derived from viral macrophage inflammatory protein II.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Changjie Chen Research Topics

Disease

15	Breast Neoplasms (Breast Cancer) 04/2021 - 02/2009
14	Neoplasms (Cancer) 04/2021 - 05/2011
4	Hepatocellular Carcinoma (Hepatoma) 03/2015 - 01/2013
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 05/2021
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 01/2013
2	Glioma (Gliomas) 04/2017 - 01/2014
2	Lung Neoplasms (Lung Cancer) 08/2012 - 05/2011
1	Fibrosis (Cirrhosis) 01/2022
1	AIDS-Related Complex (ARC) 02/2021
1	Neoplasm Metastasis (Metastasis) 06/2019
1	Bone Resorption 10/2018
1	Leukemia 01/2015
1	Acute Promyelocytic Leukemia 01/2015
1	Carcinogenesis 01/2014
1	Lymphoma (Lymphomas) 02/2013
1	Hypoxia (Hypoxemia) 01/2013
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2012
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2012
1	Adenocarcinoma of Lung 05/2011

Drug/Important Bio-Agent (IBA)

7	Paclitaxel (Taxol)FDA LinkGeneric 04/2021 - 02/2015
6	MicroRNAs (MicroRNA)IBA 04/2021 - 02/2015
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2011
5	Peptides (Polypeptides)IBA 10/2018 - 08/2011
3	LigandsIBA 05/2021 - 08/2011
3	Lipid NanoparticlesIBA 01/2021 - 10/2017
3	Pharmaceutical PreparationsIBA 01/2021 - 08/2012
3	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 10/2018 - 08/2011
3	Biological ProductsIBA 10/2018 - 02/2009
2	ResveratrolIBA 01/2021 - 10/2017
2	Biomarkers (Surrogate Marker)IBA 10/2018 - 09/2018
2	vMIP-IIIBA 10/2018 - 04/2017
2	Long Noncoding RNAIBA 10/2018 - 01/2017
2	Transcription Factors (Transcription Factor)IBA 10/2018 - 01/2015
2	Gemcitabine FDA Link 03/2015 - 11/2013
2	Arsenic Trioxide (Trisenox)FDA Link 01/2015 - 01/2014
2	SurvivinIBA 05/2011 - 02/2009
1	HydroxidesIBA 01/2022
1	Sorafenib (BAY 43-9006)FDA Link 01/2022
1	PlasticsIBA 02/2021
1	polyethylene glycol 1000IBA 01/2021
1	Succinic Acid (Succinate)IBA 01/2021
1	tocophersolanIBA 01/2021
1	Tumor Biomarkers (Tumor Markers)IBA 06/2019
1	Acid PhosphataseIBA 10/2018
1	CalciumIBA 10/2018
1	CXC ChemokinesIBA 09/2018
1	CurcuminIBA 06/2018
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 01/2017
1	U 0126 (UO 126)IBA 01/2017
1	CXCR4 Receptors (CXCR4 Receptor)IBA 01/2017
1	Propidium (Propidium Iodide)IBA 01/2017
1	S-Phase Kinase-Associated Proteins (Skp1 Protein)IBA 01/2017
1	Platelet-Derived Growth FactorIBA 03/2015
1	EnzymesIBA 01/2015
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2015
1	Retinoic Acid Receptor alphaIBA 01/2015
1	Fluorouracil (Carac)FDA LinkGeneric 01/2014
1	Mitochondrial DNA (mtDNA)IBA 02/2013
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2013
1	RotenoneIBA 01/2013
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013
1	Electron Transport Complex I (NADH-CoQ Reductase)IBA 01/2013
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2012
1	EndostatinsIBA 08/2012
1	Angiogenesis InhibitorsIBA 08/2012
1	endostar proteinIBA 08/2012
1	Chemokine ReceptorsIBA 08/2011
1	Antineoplastic Agents (Antineoplastics)IBA 05/2011
1	Grape Seed ExtractIBA 02/2009

Therapy/Procedure

6	Therapeutics 05/2021 - 12/2012
4	Drug Therapy (Chemotherapy) 04/2021 - 08/2012
1	Cell- and Tissue-Based Therapy (Cell Therapy) 05/2021